As certain variable number of tandem repeat polymorphisms are reported to exert dual, conflicting effects on the risk and prognosis of cancer [21], we compared the age at onset and clinical stages between GC patients with and without MUC5AC-u repetitive regions of 1.4, 1.8 or 2.3 kb separately. Here, MUC5AC is linked to cancer.